Recruiting In Vitro Transcribed mRNA against Cancer Immunotherapy: A Contemporary Appraisal of the Current Landscape
Over 100 innovative in vitro transcribed (IVT)-mRNAs are presently undergoing clinical trials,
with a projected substantial impact on the pharmaceutical market in the near future. Τhe idea …
with a projected substantial impact on the pharmaceutical market in the near future. Τhe idea …
An Innovative PTD-IVT-mRNA Delivery Platform for CAR Immunotherapy of ErbB (+) Solid Tumor Neoplastic Cells
Chimeric antigen receptor (CAR) immunotherapy includes the genetic modification of
immune cells to carry such a receptor and, thus, recognize cancer cell surface antigens …
immune cells to carry such a receptor and, thus, recognize cancer cell surface antigens …
In Vitro-Transcribed mRNAs as a New Generation of Therapeutics in the Dawn of Twenty-First Century: Exploitation of Peptides as Carriers for Their Intracellular …
In vitro-transcribed mRNAs (IVT-mRNAs) are easily and rapidly designed in vitro
synthesized RNA molecules. After their intracellular delivery through an efficient delivery …
synthesized RNA molecules. After their intracellular delivery through an efficient delivery …
[HTML][HTML] Hotspots and status of Fetal Alpha-Thalassemia from 2009 to 2023: a bibliometric analysis
Q Li, X Li, S He, J Li - Frontiers in Pediatrics, 2024 - pmc.ncbi.nlm.nih.gov
Objective to evaluate the research status and development hotspots of fetal α-thalassemia
by quantitatively analyzing the diagnostic status, key areas, related management measures …
by quantitatively analyzing the diagnostic status, key areas, related management measures …
Peptide and Protein Delivery
H Yokoo - Cell‐Penetrating Peptides: Design, Development …, 2023 - Wiley Online Library
The delivery of functional proteins and peptides into cells to interact with therapeutic targets
or for biological applications is an attractive challenge in life sciences. To transport such …
or for biological applications is an attractive challenge in life sciences. To transport such …
An Innovative PTD-IVT-mRNA Delivery Platform for CAR Immunotherapy of ErbB (+) Solid Tumor Neoplastic Cells
S Georgiou, A Miliotou, C Ntenti, I Pappas… - 2022 - repository-empedu-rd.ekt.gr
Chimeric antigen receptor (CAR) immunotherapy includes the genetic modification of
immune cells to carry such a receptor and, thus, recognize cancer cell surface antigens …
immune cells to carry such a receptor and, thus, recognize cancer cell surface antigens …